Int J Mol Sci 21:1
Thus, the NICE clinical guidelines, based on the AiDAPT results, recommend that HCL systems should be offered to all women, trans men and non-binary people with type 1 diabetes who are pregnant or planning to become pregnant[41]
Other Considerations: When choosing a GLP-1 analogue for weight management, factors such as medication cost, insurance coverage, and personal preferences may come into play
RATIONALE FOR DUAL OR TRIPLE AGONISTS As described above, GLP-1 RA have proven efficacy and their use has increased steadily since their launch in 2005
Itching or Tenderness Itching and mild pain are also common injection site reactions with GLP-1s like tirzepatide, semaglutide, or liraglutide
It remains an investigational compound under development by Eli Lilly and Company, currently progressing through Phase 3 clinical trials